Idexx Laboratories share price logo

Idexx Laboratories

NASDAQ: IDXX

Large Cap

$556.28

+10.19

(+1.87%)

Live

as on

Idexx Laboratories Stock Performance

as on August 19, 2026 at 6:08 am IST

  • Day's Low

    Day's High

    $549.75
    $559.46
    downward going graph

    1.17%

    Downside

    0.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $196.00
    $287.20
    downward going graph

    64.77%

    Downside

    -48.37%

    Upside

    downward going graph

Idexx Laboratories share price movements today

Previous Close
$546.09
Open
$553.73
Volume
197.9K
Market Cap
$43.4B
Day's Low - High
$549.75 - $559.46
52 Week Low - High
$196.00 - $287.20

Idexx Laboratories Historical Returns

1 Month Return
-2.9 %
3 Month Return
+ 4.19 %
1 Year Return
-15.35 %
3 Year Return
+ 13.27 %
5 Year Return
-18.75 %

Idexx Laboratories Stock Fundamentals & Key Indicators

Check Idexx Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$43.4B

EPS (TTM)

14.24

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.18%

PE Ratio (TTM)

39.81

Industry PE ratio

5.3773333333333335

PEG Ratio

2.251080607476633

EBITDA

1.6B

Revenue (TTM)

4.6B

Profit Margin

62.45%

Return On Equity TTM

71.96%

Idexx Laboratories Stock Valuation

Track how Idexx Laboratories P/E has moved over time to understand its valuation trends.

Idexx Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (38.39x)

December 31, 2024

Industry (5.38x)

December 31, 2025

Today (51.37x)

December 31, 2025

Highest (75.32x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 51.37x

Idexx Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Idexx Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$43.4B-18.75%39.8162.45%NA
BUY$44.7B209.4%-228.5165.30%NA
BUY$217.5B5.75%3240.37%0.3%
BUY$142.3B-36.92%36.1158.51%0.7100000000000001%

Stock Returns calculator for Idexx Laboratories Stock including INR - Dollar returns

The Idexx Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Idexx Laboratories investment value today

Current value as on today

₹93,654

Returns

-₹6,346

(-6.35%)

Returns from Idexx Laboratories Stock

-₹14,529 (-14.53%)

Dollar Impact

₹8,183 (+8.18%)

Analyst Recommendation on Idexx Laboratories Stock

Based on 7 analysts

BUY

57.14%

Buy

42.86%

Hold

0.00%

Sell

Based on 7 analysts, 57.14285714285714% of analysts recommend a 'BUY' rating for Idexx Laboratories. Average target price of $698.92

Idexx Laboratories Share Price Target

Get share price movements and forecasts by analysts on Idexx Laboratories.

What analysts predicted

20.41%UPSIDE

Target Price

$698.92

Current Price

$556.28

Analyzed by

7 Analysts

Target

$698.92

Idexx Laboratories target price $698.92, a slight upside of 20.41% compared to current price of $556.28. According to 7 analysts rating.

Indian Investors' Interest in Idexx Laboratories Stock

Search interest for Idexx Laboratories Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:41% versus previous 30 day period

Idexx Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
964
1,003
975
954
998
1,109
1,105
1,090
1,140
1,216
Gross Profit
593
620
596
570
623
694
683
658
722
779
Operating Income
298
263
303
261
316
373
354
315
362
425
EBITDA
334
300
341
298
351
409
392
356
400
468
Interest Expense
7
8
7
7
7
11
10
10
7
10
Depreciation
29
32
34
33
34
35
36
38
37
41
Income Before Tax
295
259
298
256
310
362
344
306
355
417
Income Tax Expense
59
55
66
40
67
68
70
58
76
78
Net Income
235
203
232
216
242
293
274
248
278
338
Net Profit Margin
61.52%
61.87%
61.10%
59.80%
62.44%
62.62%
61.83%
60.35%
63.35%
64.04%

Idexx Laboratories Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,969
2,213
2,406
2,706
3,215
3,367
3,660
3,897
4,303
Gross Profit
1,097
1,241
1,365
1,571
1,889
2,004
2,189
2,378
2,659
Operating Income
413
491
552
694
932
898
1,097
1,128
1,360
EBITDA
501
575
643
793
1,039
1,014
1,217
1,275
1,468
Interest Expense
37
34
31
33
29
39
41
31
38
Depreciation
83
83
88
95
104
111
114
129
106
Income Before Tax
381
457
522
661
902
859
1,061
1,109
1,324
Income Tax Expense
117
80
94
79
157
180
216
221
264
Net Income
263
377
427
581
744
679
845
887
1,059
Net Profit Margin
55.73%
56.10%
56.73%
58.04%
58.76%
59.52%
59.82%
61.04%
61.80%

Idexx Laboratories Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
235
203
232
216
242
293
274
248
278
338
Operating Cash Flow
198
248
220
262
237
185
402
352
266
347
Investing Cash Flow
-106
-32
-27
-39
-29
-33
-44
-28
-33
-25
Financing Cash Flow
-144
-210
-290
-232
-330
-165
-313
-351
-211
-325
Change in Cash
-56
4
-92
-20
-124
0
43
-28
20
-3

Idexx Laboratories Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
263
377
427
582
744
679
845
887
1,059
Operating Cash Flow
373
400
459
648
755
542
906
929
1,178
Investing Cash Flow
-138
138
-205
-109
-292
-195
-125
-207
-136
Financing Cash Flow
-208
-597
-286
-248
-697
-370
-441
-878
-1,161
Change in Cash
32
-63
-33
293
-239
-31
341
-165
-108

Mutual Funds that own Idexx Laboratories Stock

Check out the Mutual Funds with significant holdings in Idexx Laboratories.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
10.032464%
7903687
Fidelity Concord Street Trust
1.782052%
1403921
IVY FUNDS
1.266778%
997982
BARON SELECT FUNDS
1.096201%
863600
Fidelity Salem Street Trust
1.061298%
836103

Global Institutional Holdings in Idexx Laboratories

Funds
Holdings
Vanguard
11.14%
iShares
7.05%
Invesco
5.16%
SPDR
3.99%
Xtrackers
1.16%

Idexx Laboratories News & Key Events

  • img

    Today's Timeline - 28 July

    Tue, 07:36 PM

    -

    IDEXX releases 2025 Corporate Responsibility Report, highlighting innovation, sustainability, and support for over 45,000 animals in underserved communities.

Insights on Idexx Laboratories

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    IDEXX Laboratories, Inc. has shown a positive trend in its net profit over the last three quarters. The net profit increased from $248.18 million to $338.41 million, reflecting an average growth of 14.3% per quarter.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    IDEXX Laboratories, Inc. has seen a positive revenue trend over the last three quarters, with revenue increasing from $1.09 billion to $1.21 billion. This represents an average growth of 5.3% per quarter.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 497.3% return, outperforming this stock by 484.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 95.0% return, outperforming this stock by 109.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IDXX stock has moved down by -6.9%

About Idexx Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
OrganisationIdexx Laboratories
HeadquartersOne IDEXX Drive, Westbrook, ME, United States, 04092
IndustryDiagnostics & Research
CEOMr. Michael G. Erickson Ph.D.
E-voting on sharesClick here to vote

Key Management of Idexx Laboratories

Name

Title

Mr. Andrew Emerson

Executive VP, CFO & Treasurer

Mr. Michael J. Lane

Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology

Mr. Michael G. Erickson Ph.D.

CEO, President & Director

Mr. Michael P. Johnson

Executive VP & Chief Human Resources Officer

Mr. Jonathan J. Mazelsky

Executive Chairman

Dr. Martin Smith Ph.D.

Executive Vice President of Global Operations and R&D

Mr. Bob Asmann

Senior Vice President of Global Operations

Mr. Amit Gupta

Senior VP, Chief Digital & Information Officer

Ms. Sharon E. Underberg J.D.

Executive VP, General Counsel, & Corporate Secretary

Ms. Julie Godon

Senior VP & Global Marketing Officer

FAQs

What is Idexx Laboratories share price today?

Idexx Laboratories share price today is $556.28 as on . Idexx Laboratories share today touched a day high of $559.46 and a low of $549.75.

What is the 52 week high and 52 week low for Idexx Laboratories share?

Idexx Laboratories share touched a 52 week high of $287.20 on and a 52 week low of $196.00 on . Idexx Laboratories stock price today i.e. is trending at $556.28,which is -93.69% down from its 52 week high and 183.82% up from its 52 week low.

What is Idexx Laboratories's market capitalisation today?

Idexx Laboratories market capitalisation is $0.04T as on .

How to invest in Idexx Laboratories Stock (IDXX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Idexx Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Idexx Laboratories Shares that will get you 0.0027 shares as per Idexx Laboratories share price of $556.28 per share as on August 19, 2026 at 12:38 am IST.

What is the minimum amount required to buy Idexx Laboratories Stock (IDXX) from India?

Indian investors can start investing in Idexx Laboratories (IDXX) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Idexx Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Idexx Laboratories share’s latest price of $556.28 as on August 19, 2026 at 12:38 am IST, you will get 0.0180 shares of Idexx Laboratories. Learn more about fractional shares .

What are the returns that Idexx Laboratories has given to Indian investors in the last 5 years?

Idexx Laboratories stock has given -18.75% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?